🇺🇸 FDA

Drug profile · INN

crisaborole

STAQUIS

FDA: approved EMA: withdrawn D11AH06
US status
approved
Patents linked
0
News articles
0

Quick answer

crisaborole (STAQUIS) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.

Key facts

INN crisaborole
Brand STAQUIS
Route TOPICAL
Formulation OINTMENT
ATC code D11AH06

Frequently asked questions

What is crisaborole?

crisaborole (STAQUIS) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.

What is the brand name for crisaborole?

STAQUIS is a marketed brand name for crisaborole. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of crisaborole?

crisaborole has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.